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ABSTRACT Interleukin-22 (IL-22) is a class 2 cytokine whose primary structure is similar to that of interleukin 10 (IL-10) and
interferon-g (IFN-g). IL-22 induction during acute phase immune response indicates its involvement in mechanisms of inﬂam-
mation. Structurally different from IL-10 and a number of other members of IL-10 family, which form intertwined inseparable
V-shaped dimers of two identical polypeptide chains, a single polypeptide chain of IL-22 folds on itself in a relatively globular
structure. Here we present evidence, based on native gel electrophoresis, glutaraldehyde cross-linking, dynamic light scat-
tering, and small angle x-ray scattering experiments, that human IL-22 forms dimers and tetramers in solution under protein
concentrations assessable by these experiments. Unexpectedly, low-resolution molecular shape of IL-22 dimers is strikingly
similar to that of IL-10 and other intertwined cytokine dimeric forms. Furthermore, we determine an ab initio molecular shape of
the IL-22/IL-22R1 complex which reveals the V-shaped IL-22 dimer interacting with two cognate IL-22R1 molecules. Based on
this collective evidence, we argue that dimerization might be a common mechanism of all class 2 cytokines for the molecular
recognition with their respective membrane receptor. We also speculate that the IL-22 tetramer formation could represent a way
to store the cytokine in nonactive form at high concentrations that could be readily converted into functionally active monomers
and dimers upon interaction with the cognate cellular receptors.
INTRODUCTION
Interleukin-22 (IL-22) is a novel cytokine primarily identi-
fied in murine CD41 T cells upon induction with IL-9, and,
later, in human cells (see (1–3) for reviews). IL-22 mediates
acute-phase response signals in hepatocytes, eliciting the pro-
duction of acute-phase reactive proteins. Its known target or-
gans include pancreas, skin, liver, gastrointestinal tract, and
kidneys. IL-22 induces pancreatic-associated protein, PAP1,
in acinar cells and the antimicrobial proteins b-defensin 2 and
3 and psoriasin in human keratinocytes. The biological func-
tion of this cytokine, therefore, is to promote antimicrobial
defense of the outer barriers (skin, lungs, gastrointestinal tract),
directly stimulating the innate immune response of tissues
(4). Furthermore, IL-22 acts as an effector cytokine and me-
diates communication between immune system and epithe-
lial cells by modulating IL-23 response in physiological and
pathological immune responses such as dermal inflammation
and acanthosis (5).
Human and murine IL-22 orthologs encode 179 amino-
acid proteins that are 79% identical to each other, bearing
just 22% (human) and 25% (mouse) identity with their IL-10
paralogs. IL-22 is a member of the IL-10 family of cytokines
(comprising also IL-19, -20, -24, -26, -28(A/B), and -29),
proteins involved in cell signaling which triggers immune
response (reviewed in (2)). IL-10 family belongs to Class 2
cytokine superfamily, which also includes interferons type I
and type II. Interferon-g (IFN-g) is the only type II inter-
feron, and both human and murine IL-22 genes are chromo-
somally located in a close proximity of the IFN-g gene (6).
Class 2 cytokines bind to their specific receptors, which
include tissue factor, IFN-gR1, IFN-gR2, IL-10R1, IL-
10R2, IL-20R1, IL-20R2, IL-28R, and IL-22R1 (7). The
extracellular cytokine-binding domain of these receptors is
composed of two fibronectin type III domains, each
consisting of two antiparallel b-sheets, formed by seven
b-strands (8–12). On the cell surface, IL-22 binds to two
receptors: an IL-22 specific receptor chain termed IL-22R1,
and a second component of IL-10 receptor, IL-10R2, shared
with IL-10, IL-26, IL28, and IL-29 (13,14). The IL-22R1
ligand-binding chain is mostly expressed in tissues of the
digestive tract, whereas the IL-10R2 is a ubiquitously
expressed signal-transducing chain (15,16). Enzyme-linked
immunoabsorbant assay-based studies showed that IL-22
first binds to IL-22R1 and only afterwards does the IL-22/IL-
22R1 complex expose an interface that is able to bind the IL-
10R2 receptor chain (17). Supporting this model, another
line of evidence showed that affinity interaction between IL-
22 and IL-22R1 is in the nanomolar range, whereas that of
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IL-22 and IL-10R2 is in the millimolar range (18,19).
Therefore, the assembly of the ternary IL-22/IL-22R1/IL-
10R2 receptor complex shows sequential interactions dic-
tated by the affinity of the pairing, before eliciting signaling
on the cell membrane.
This simultaneous and complementary receptor recogni-
tion leads to activation of cytokine-specific signal transduc-
tion pathways. Upon binding to its receptors, IL-22 induces
Jak1 and Tyk2 phosphorylation, activates three major MAP
kinases pathways, and promotes activation of STAT (signal
transducer and activation transcription factors) -1, -3, and -5
as measured by STAT-responsive promoter activation. STAT
proteins translocate to the nucleus and activate the transcrip-
tion of genes involved in IL-22 biological response (1,2).
Recombinant IL-22 has been produced both in Escherichia
coli and Drosophila melanogaster S2 cells, purified to
homogeneity and crystallized (20,21). Crystallographic stud-
ies of IL-22 revealed that the protein folds in an a-helical
bundle with tertiary structure strikingly different from IL-10
architecture (11,18,22,23). Unlike IL-10, which exists as an
intimate intertwined dimer forming a symmetric V-shaped
molecule, bacterially expressed IL-22 is arranged in a crystal
as an asymmetric dimer of two separate and independent
molecules (24), and IL-22 crystals of protein produced in S2
insect cells contain six molecules in the asymmetric unit
organized in three noncovalent dimers (21). Comparisons
between IL-22/IL-22R1 homology model and equivalent
residues involved in the cytokine-receptor binding of IL-10/
IL-10R1 and IFN-g/IFN-gR1 complexes suggest that IL-22
dimerization is probably an artifact of crystallization (21,24).
Indeed, IL-22 amino-acid residues, from the putative IL-
22R1 binding site, interact with other IL-22 molecules, and
this incidental interaction is stabilized in the crystallographic
arrangement. As a result, IL-22R1 binding site is hidden at
the dimer molecular interfaces observed in crystal structures
(21,24). If the structure of IL-22 adopted in solution is
similar to that observed in crystallographic arrangements, it
should hamper IL-22 recognition by the IL-22R1 receptor
under physiological conditions.
To determine oligomeric state and to structurally charac-
terize human IL-22 alone and in the complex with its high-
affinity cognate receptor IL-22R1, we used dynamic light
scattering, glutaraldehyde cross-linking, native gel electro-
phoresis, and small angle x-ray scattering (SAXS), a method
of choice for experimental determination of protein quater-
nary structure and its molecular shape in solution (25,26).
Our results reveal that under the experimental conditions IL-
22 forms dimers and tetramers, and that SAXS-derived low
resolution models of IL-22 dimers are surprisingly similar to
the low resolution shape of the IL-10 intimate intertwined
dimers. Furthermore, low resolution shape of IL-22 tetra-
mers closely resembles tetrameric organization of IFN-g
crystallographic structure (10). Finally, we determined a low
resolution ab initio molecular shape of the IL-22/IL-22R1
complex and demonstrated that it is composed of an IL-22
dimer recognized by two IL-22R1 receptors. Based on this
collective evidence, we speculate that IL-22 interaction with
its cognate receptors, similar to other class 2 cytokines,
involves dimerization; and that the tetrameric form of the
cytokine might represent inactive stock of IL-22, which
dissociates into smaller multimeric forms upon interactions
with its respective receptors on the cell surface.
MATERIALS AND METHODS
Protein expression and puriﬁcation
Human IL-22 (residues 29–179) was purified from inclusion bodies as
described previously (24). The purity of the IL-22 was estimated by SDS-
PAGE and the concentration determined by UV absorbance. Protein bio-
activity was assessed as described (27) and recombinant IL-22 protein was
found to be fully active. Recombinant human IL-22R1 was produced in
E. coli as follows. The IL-22R1 extracellular domain (corresponding to
amino acids P18–T228) was cloned into a derivative of plasmid pET3A
(Stratagene, La Jolla, CA). An additional glycine was added in front of P18
to avoid heterogenous processing of the N-terminal methionine. In addition,
cysteine 204, which is not conserved in IL22R1 of other species, was
mutated to leucine. Functional cellular assay of the mutated C204L receptor
showed that it retains full activity. E. coli strain BL21-AI (Invitrogen Life
Technologies, Paisley, UK) was used as the expression host. Mutated IL-
22R1 was expressed as inclusion bodies. Inclusion bodies were purified as
previously described (24,27) and solubilized in 6 M guanidine hydrochlo-
ride, 25 mM sodium acetate (pH 5.5). The purity of the IL-22R1 was esti-
mated at 80% based on SDS-PAGE and Coomassie-blue staining analysis.
The IL-22R1 protein was refolded by direct dilution of the solubilized
inclusion bodies in the following folding mixture: 25 mg/ml IL-22R1, 50
mM Tris-HCl, 2 mM EDTA, 0.5 M L-arginine, 1 mM reduced glutathione,
and 0.1 mM oxidized glutathione (pH 8.5). The solution was incubated for
1–2 weeks at 4C. Then, glycerol and CHAPS (CALBIOCHEM, Darmstadt,
Germany) were added at 10% (v/v) and 1 mM, respectively. The folding
mixture was then concentrated by ultrafiltration and purified on a Superdex200
gel filtration column (GE Healthcare Bio-Sciences AB, Uppsala, Sweden).
The protein was eluted with 25 mMBicine, 150mMNaCl, and 1 mMCHAPS
(pH 9.5). IL2/IL22R1 complex was obtained by mixing of purified IL22 and
IL22R1 at a molar ratio of ;1.2 (IL22/IL22R1) in 25 mM Bicine, 150 mM
NaCl, and CHAPS 1 mM (pH 9.5) and incubated overnight at 4C. The
complex was purified on a Superdex200 gel filtration column with 25 mM
Bicine, 150 mM NaCl, and 1 mM CHAPS (pH 9.5) as elution buffer and
concentrated by ultrafiltration to 5 mg/ml.
Native polyacrylamide gel electrophoresis
(native PAGE)
The electrophoresis was performed in 8–25% polyacrylamide gradient gel
using the PhastSystem (Pharmacia, Peapack, NJ) according to the manu-
facturer’s protocol. Molecular mass calibration kit containing the following
proteins—97 kDa, phosphorylase b; 66 kDa, bovine serum albumin; 45 kDa,
ovalbumin; 30 kDa, carbonic anhydrase; 20.1 kDa, soybean trypsin in-
hibitor; and 14.1 kDa, a-lactalbumin (Amersham Biosciences, Piscataway,
NJ)—was run in parallel with sample to estimate molecular weights.
Glutaraldehyde cross-linking
IL-22 aliquots (2 mg) in 25 mM HEPES, 150 mM NaCl (pH 8) were
incubated with 0.00–0.05% (v/v) glutaraldehyde (Merck, Whitehouse
Station, NJ) in a total volume of 10 ml at 25C for 30 min. Reactions
were stopped by addition of SDS-PAGE loading dye and the products
analyzed by SDS-PAGE.
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Dynamic light scattering experiments
IL-22 oligomerization state was assessed by dynamic light scattering (DLS).
DLS measurements were performed with a DynaPro MS200 instrument
(Protein Solutions, Salt Lake City, UT) at 4C using a 12 ml cuvette.
Concentrated IL-22 protein (10 mg/ml) was sequentially diluted to 5, 2.5,
1.25, 0.625, and 0.325 mg/ml in 10 mM Tris-HCl, 10 mM NaCl (pH 8)
before measurements.
Small-angle x-ray scattering data acquisition
SAXS data were measured at the small-angle scattering beamline of the
National Synchrotron Light Laboratory (Campinas, Brazil) using a one-
dimensional position-sensitive detector (28) as described previously (29).
IL-22 scattering was measured at concentrations of 10, 5, and 2.5 mg/mL in
10 mM Tris-HCl, and 10 mM NaCl, pH 8, and IL-22/IL-22R1 at 3.5 mg/mL
and 1.0 mg/mL, in 20 mM Bicine, 150 mM NaCl, and 1 mM CHAPS, pH
9.5 (Fig. 1). Since our SAXS curves in all cases exhibit a wide range of
Guinier behavior, without any significant positive deviation at very small q
and with radii of gyration derived from Guinier plots that are compatible
with those of the proposed models, we can safely conclude that no effects of
protein aggregation were occurring under experimental conditions. Samples
were measured at the wavelength l ¼ 0.1488 nm, with detector/sample dis-
tance of 1033 mm, covering the momentum transfer range 0.15 , q , 3.5
nm1 (q ¼ 4psinu/l, where 2u is the scattering angle). The protein solutions
and buffer were exposed in 1-min frames to monitor radiation damage and
beam stability. Scattering from the buffer was subtracted after the data being
normalized to the intensity of the incident beam and corrected for detector
response, and the difference curves were scaled for concentration.
Scattering data analysis
SAXS analysis was carried out using the ATSAS program package (30). The
distance distribution functions p(r) and the radii of gyration (Rg) were
evaluated by the indirect Fourier transform program GNOM (30). Low
resolution particle shapes of IL-22 multimers were restored from the
FIGURE 1 Experimental solution scattering curves of IL-22 (log I versus q) and results of the fitting procedures for (A) IL-22 dimer, experimental curve after
subtraction of a constant value as described in Materials and Methods (solid spheres with error bars); scattering intensity from the DAMs (DAMMIN) (solid
line); from the proposed high-resolution model (dash-dot); from IL-10 (dash); and from the crystallographically observed IL-22 dimer (30) (dash-dot-dot). (B)
IL-22 tetramer, experimental curve (solid spheres with error bars); scattering intensity from the DAMs (DAMMIN) (solid line); from the proposed high-
resolution model (dash-dot); and from IFN-g tetramer (dots). (C) IL-22/IL-22R1, experimental scattering curve (solid spheres with error bars); scattering
intensity from the DAMs (DAMMIN) (solid line); from the proposed high-resolution model (dash-dot); and from IL-10/IL-10R1 (short dash). Insets display
the correspondent Guinier plots (log I versus q2). (D) Experimental intensities I(q)/c versus q for IL-22 dimer (open circles) and IL-22 tetramer (open squares)
are superposed with I(q)/c extrapolated to zero scattering angle for IL-22 dimer (solid line) and IL-22 tetramer (dash line).
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experimental SAXS data using two ab initio procedures. In the first method,
the shape is described by an angular envelope function, parameterized in
terms of spherical harmonics, using multipole expansion techniques. The
maximum number of the spherical harmonics is selected to keep the number
of free parameters close to the number of Shannon channels in the experi-
mental data (31). The envelopes were obtained with the SASHA program
(30). In the second method, the low resolution shapes were restored from the
experimental data using a separate ab initio procedure implemented in
DAMMIN (30). In this program, the particle is represented by the dummy
atom model (DAM) and a simulated annealing protocol is used to search for
a compact interconnected model compatible with the data.
If I(q) is given in absolute units, the extrapolated SAXS intensity, I(0),
corresponding to a dilute and monodisperse set of N scattering objects per
unit volume, can be written as (26)
Ið0Þ ¼ NðDrÞ2v2; (1)
where Dr is the difference in electron density between the protein and the
surrounding solvent and v is the volume of the protein assembly. The
product N.v and the difference Dr in Eq. 1 remain approximately constant
and independent of the degree of protein association and thus the quotient
I(0)/c is given by
Ið0Þ
c
¼ k:v; (2)
k being a constant. Equation 2 tells us that I(0)/c is proportional to the
monomer/multimer volume. Thus, even if the SAXS intensity is known in
relative units, the experimental values of I(0) for different protein concen-
tration can be used to determine the presence of transitions involving different
types of multimers and eventually to check the validity of independent
findings about the presence and nature of these transitions. For example, for a
dimer-to-tetramer transition for which vtetramers ﬃ 2:vdimers, the experimental
value of I(0)/c for tetramers is expected to be two times I(0)/c for dimers.
High-resolution modeling of IL-22
The coordinate set for IL-22 monomer was obtained from the Protein Data
Bank (PDB ID: 1YKB and 1M4R) (21,24). IFN-g and IL-10 coordinates
(PDB ID: 1FYH and 1ILK, respectively) were similarly obtained (10,23).
The crystallographic models of monomeric IL-22 could be unambiguously
positioned inside the DAM for the IL-22 dimer. Relative positions of IL-22
were found by iterative rotation of its envelope functions to minimize the
discrepancy with the ab initio low-resolution structure, using an automated
procedure. Two models of the solution IL-22 dimers were placed within the
tetramer ab initio envelopes allowing for their relative rotation and transla-
tion around a common twofold axis. The models were displayed using the
programMASSHA (30). Radii of gyration, maximum intraparticle distances
(Dmax), envelope functions, and scattering curves were calculated from these
atomic coordinates with use of the program CRYSOL (30) taking into
account the influence of the hydration shell. SUPCOMB (30) was used to
superimpose ab initio low-resolution models with the crystallographic
structure. Figures for the SAXS IL-22 dimer and tetramer were generated in
the program PyMOL (32).
Rigid-body modeling of the IL-22/IL-22R1 complex
One IL-22 monomer was superimposed with each domain of IL-10 dimer in
the IL-10/IL-10R1 template structure (PDB ID: 1J7V) (11) using CCP4
superpose (33). IL-22R1 was obtained by homology modeling using IL-
10R1 starting model and also superimposed with the same IL-10/IL-10R1
template. This search structure, as well as the IL-10/IL-10R1 complex, did
not fit well the experimental SAXS data. Therefore, it was further separated
in two equal subunits containing one IL-22 and one IL-22R1 each, and their
relative position and orientation were minimized using SASREF program
against SAXS curve (30). The intermolecular contacts mediated by DE loop
were maintained during the minimization procedure. CRYSOL (30) was
used to evaluate the high-resolution model parameters and SUPCOMB (30)
was used to superimpose the model with ab initio DAM. Figures for the
SAXS IL-22/IL-22R1 complex were generated in the program PyMOL (32).
Sequence alignment
IL-22 homologs protein sequences were retrieved from the nonredundant
database using PSI-BLAST (34) and aligned with the program ClustalW (35).
RESULTS
SAXS, dynamic light scattering, native page,
and cross-linking experiments reveal IL -22
dimers and tetramers in solution
By comparison with a reference solution of bovine serum
albumin, SAXS studies showed that IL-22 is present predom-
inantly as dimers of 32 6 3 kDa, at concentrations below
2.5 mg/ml, whereas the protein forms mostly tetramers of
molecular weight 63 6 5 kDa, at concentrations above 5
mg/ml. The experimental intensities extrapolated to zero
angle normalized by the concentration, I(0)/c, derived from
the SAXS curves, are plotted in Fig. 1 D. The I(0)/c for a
protein solution with the concentration c ¼ 5.0 mg/ml is
approximately two times that corresponding to c ¼ 2.5
mg/ml, ([I(0)/c]5.0mg/ml ¼1.85 6 0.1 [I(0)/c]2,5mg/ml). As
explained in Scattering Data Analysis (Eq. 2), this finding
confirms the presence of a dimer-to-tetramer transition for
protein solutions with concentrations changing from c ¼ 2.5
mg/ml to c ¼ 5 mg/ml, independently deduced from GNOM
and DAMMIN analyses. Further evidence of IL-22 oligo-
merization in solution comes from dynamic light scattering
measurements. As determined by DLS IL-22, the protein
Stokes radius varies from 3.5 nm at high concentrations to
2.9 nm at lower concentrations. These results favorably
agree with the Stokes radii calculated on the basis of the ab
initio low-resolution SAXS models of the IL-22 dimer and
tetramer, which are 2.9 nm and 3.3 nm, respectively (36).
The experimental value of Dmax and Rg, respectively, 8.0
nm and 2.74 nm for the dimer, and 11 nm and 3.25 nm for the
IL-22 tetramer, suggest that the protein is of approximately
globular shape in both oligomerization states (Table 1). This
notion is also supported by the profiles of the distance dis-
tribution functions p(r) (Fig. 2), which are typical of globular
prolate particles (37).
Moreover, separation of IL-22 on an 8–25% native PAGE
gradient gel showed a predominant band of 65 kDa, corre-
sponding to the size of the tetrameric form and another faint
band with a molecular weight of 33 kDa, which corresponds
to the IL-22 dimer (Fig. 3 A). These oligomeric forms of
IL-22 were also observed by glutaraldehyde cross-linking
experiments; the presence of three bands, located at mono-
mer (17 kDa), dimer (35 kDa), and tetramer (70 kDa)
positions, indicates the ability of IL-22 to assemble as dimers
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and tetramers (Fig. 3 B). These results are in agreement with
the observations of SAXS (Table 1) and DLS experiments,
and indicate a thermodynamic equilibrium between IL-22
oligomerization states. Taken together these studies strongly
suggest that IL-22 protein is present as dimers and tetramers
in solution.
Ab initio IL-22 and IL-22/IL-22R1 molecular
shape determination
First, shape determinations of the IL-22 dimers, IL-22 tetra-
mers, and IL-22/IL-22R1 complex were performed using
multipole expansion methods. The experimental data were
fitted ab initio by the scattering from an envelope function
starting from a spherical initial approximation. The molecular
envelope of the IL-22 dimer, obtained by this method, is
V-shaped and has two well-developed lobes (Fig. 4 A), whereas
the molecular envelope for IL-22 tetramer is X-shaped and has
four separate domains (Fig. 5 A). Molecular envelope of the
IL-22/IL-22R1 complex is prolate and elongated (Fig. 6 A).
The particle shapes were also computed from the IL-22
and IL-22/IL-22R1 experimental data by the ab initio proce-
dure implemented in the DAMMIN program (30). No sym-
metry restraints were applied. Twenty independent ab initio
simulations were performed, and 760 6 20 dummy atoms
were attributed to the final model of IL-22 dimer, as well as
6906 30 atoms were assigned to the final model of the IL-22
tetramer and 1286 6 24 atoms were assigned to the final
model of the IL-22/IL-22R1 complex.
To verify the uniqueness of the shape restoration using
DAMs (Figs. 4 B, 5 B, and 6 B), several independent res-
torations were performed using different starting conditions,
which all converged to similar molecular shapes. Maximum
concentrations of the protein used for SAXS solution studies
of the IL-22 dimers, tetramers, and the IL-22/IL-22R1
complex limited the maximum resolution of the final models
to 4.2 nm, 1.8 nm, and 3.1 nm, respectively (Table 1). This
resolution does not permit unambiguous determination of the
spatial positions of their secondary structure elements, but
allowed us to obtain the overall shapes of the IL-22 and IL-
22/IL-22R1 complexes and relative positions of their sub-
units. It is important to stress that the use of two independent
ab initio reconstructions of SAXS data for the IL-22 and IL-
22/IL-22R1 molecular envelopes yielded very consistent and
coherent results.
IL-22 dimers mimic IL-10 quaternary arrangement
The SAXS-derived IL-22 dimer model is an open V-shaped
molecule with two clearly developed substructures each com-
prising one IL-22 monomer (Figs. 4 A and 5 B). Attempts to
fit this model with IL-22 crystallographic dimers described
previously (21,24) were proved to be unsuccessful (Fig. 1 A).
Moreover, solution IL-22 dimer distance-distribution func-
tion is grossly different from that of IL-22 dimer observed
in crystals (Fig. 2 A). Finally, IL-22 crystallographic dimer
could not be convincingly superimposed with the IL-22 low-
resolution structure. Failure to fit ab initio, low-resolution
IL-22 structure with IL-22 dimers observed in crystals,
prompted us to analyze IL-22 multimers in more detail and to
compare them with the multimeric assemblies of other class-2
cytokines. Strikingly, we found that IL-22 dimer structure is
very similar to the IL-10 intertwined dimer (22–24,38). The
V-opening angle is ;90 for both IL-22 and IL-10, and the
relative positions and orientations of the IL-10 domains are
almost identical to those of IL-22 monomers forming a
dimer. This is clearly observed by the superposition of both
structures presented in Fig. 4 C. Collectively, analysis of
IL-22 SAXS models suggest a completely different struc-
tural organization for IL-22 molecules in solution which
mimic IL-10 intertwined dimer.
IL-22 tetramers are similar to IFN-g
crystallographic tetramer
The IL-22 tetramer is an oblate and somewhat twisted
X-shaped molecule (Fig. 5, A and B). Similarly to the IL-22
dimer, ab initio tetramer low-resolution structure contains
well-developed lobes, or domains, that correspond to the indi-
vidual monomers. The tetramer can be thought of as a dimer
of V-shaped dimers bound through molecular interactions at
the base of the V. Neither E. coli-expressed nor insect-cell-
derived crystallographic IL-22 dimer can convincingly ex-
plain our experimental SAXS data, because simulated x-ray
TABLE 1 SAXS parameters for IL-22 dimer and tetramer and IL-22/IL-22R1
Parameter
IL-22 dimer IL-22 tetramer IL-22/IL-22R1
Exp.* Mody DAMz/Env§ Exp.* Mody DAMz/Env§ Exp.* Mody DAMz/Env§
Dmax (nm) 8.0 6 0.5 8.2 8.2/10.4 11.0 6 0.5 10.5 10.8/11.0 11.5 6 0.5 13.0 11.9/13.5
Rg (nm) 2.74 6 0.06 2.83 2.78/2.94 3.25 6 0.04 3.32 3.32/3.51 3.56 6 0.02 3.34 3.48/3.59
Discrepancy x — 1.80 1.81/1.41 — 1.75 1.73/1.62 — 1.31 1.20/1.23
Resolution (nm) 4.2 — 4.2/4.2 1.8 — 1.8/1.8 3.1 — 3.1/3.1
*Calculated from the experimental data.
yParameters of the proposed high-resolution structures.
zParameters of the dummy atoms models averaged over 20 models.
§Parameters of the envelope models obtained from SASHA.
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scattering curves for these assemblies do not fit well exper-
imental low-resolution scattering intensities. In addition, their
distance distribution functions are very different from the ex-
perimentally derived one. Furthermore, these high-resolution
structures cannot be adequately superimposed with the ab
initio low-resolution IL-22 tetramer model (results not shown).
Since none of the crystallographic assemblies of IL-22 proved
to be suitable for modeling the low-resolution envelope of
the tetramer, we systematically tested multimers of other
class-2 cytokines observed in x-ray crystal structures. By
fitting of high-resolution crystallographic models into the
low-resolution molecular envelope, we found a high simi-
larity of the ab initio low-resolution structure of IL-22 tet-
ramer and the packing of the crystal homodimeric structure
of single chain monovalent human interferon-g (ScIFN-g),
described by Randal and Kossiakoff (10). The SAXS-
derived high resolution IL-22 tetramer model, built from two
IL-22 high-resolution dimers models assembled in accor-
dance with scIFN-g quaternary structure arrangement, fit
well both experimental x-ray scattering data (Fig. 1 B) and
the distance distribution function (Fig. 2 B). Furthermore, it
is also consistent with two independently generated ab initio
FIGURE 2 Distance distribution functions of the IL-22 dimer (A), distance
distribution functions: from the experimental x-ray scattering data (solid
sphereswith error bars); from the proposed high-resolution model (dash-dot);
and from the IL-22 dimer observed in crystal structure (PDB ID 1M4R) (dash-
dot-dot) and from IL-10 (dash). IL-22 tetramer (B), distance distribution
functions: from the experimental x-ray scattering data (solid sphereswith error
bars); from the proposed from the proposed high-resolution model (dash-dot);
and from IFN-g tetramer (dots). IL-22/IL-22R1 (C), distance distribution
functions: from the experimental x-ray scattering data for (solid spheres with
error bars); from the proposed from the proposed high-resolution model
(dash-dot); and from IL-10/IL-10R1 (short dash).
FIGURE 3 IL-22 forms dimers and tetramers in solution. (A) Electro-
phoresis pattern of purified IL-22 revealed by native gel electrophoresis.
Lane 1, molecular weight calibration standards; Lane 2, IL-22 (0.5 mg/ml).
Samples were run on 8–25% gradient gel using the PhastSystem and bands
were visualized by Coomassie-blue staining. (B) Glutaraldehyde cross-
linking of IL-22. The IL-22 aliquots (2 mg) were cross-linked with 0.000%
(lane 2), 0.005% (lane 3), 0.010% (lane 4), 0.020% (lane 5), and 0.050%
(lane 6) glutaraldehyde for 30 min at 25C. Reactions were stopped by
addition of SDS-PAGE loading dye and the products analyzed by SDS-
PAGE and silver staining. Dimer (D) and Tetramer (T) bands are indicated.
Molecular markers and their weights are given (lane 1, A and B).
IL-22 Dimers Recognized by Two IL-22R1s 1759
Biophysical Journal 94(5) 1754–1765
low resolution structures of IL-22 tetramer, as shown in the
superposition of Fig. 5, A and B. Thus, it seems clear that
solution IL-22 tetramer structure is similar to the tetrameric
organization of IFN- g crystallographic structure (Fig. 5 C).
IL-22/IL-22R1 solution structure is similar but
not identical to crystallographic
IL-10/IL10-R1 complex
To gain more insights into the physiological relevance of the
observed IL-22 multimeric forms, we decided to study a
macromolecular complex between IL-22 with its high-
affinity cellular receptor IL-22R1. Since IL-22 recognition
by IL-22R1 is directly relevant to a signaling by this class-2
cytokine on a cellular level, we generated the low resolution
shape of the IL-22/IL-22R1 complex using SAXS technique
as described above. The obtained low-resolution structure of
IL-22/IL22R1 leaves no doubt regarding its oligomerization
state (Fig. 6, A and B). IL-22/IL-22R1 complex is composed
by an IL-22 dimer and two IL-22R1 receptors, each receptor
interacting with one IL-22 monomer. The intramolecular
interface of this complex is composed of the loop DE
interactions mediating interactions between two IL-22
monomers in the dimer, and the interactions between two
IL-22R1 receptors. IL-22/IL22R1 complex architecture is
similar, but not identical to that of IL-10/IL-10R1 crystal-
lographic model (Fig. 6 C), in which the later interactions
are absent. Furthermore, the angle between monomer in the
IL-22 dimer is more open due to the interactions between
N-terminal regions of IL-22R1s. These conformational
changes are not surprising given a high flexibility of the loop
DE described by Nagem and co-workers (24) resulting in a
much weaker dimerization interface between two IL-22 mol-
ecules in the dimer, as opposed to the relatively rigid structure
of the intimate intertwined IL-10 dimer. Despite aforemen-
tioned differences in the relative orientations between IL-22/
IL-22R1 and IL-10/IL-10R1 complexes, a similarity in their
quaternary architecture is evident (Fig. 6, C and D).
FIGURE 4 SAXS ab initio envelope for IL-22 dimer structure and
proposed high-resolution model based on IL-10 dimer. (A) Three orthogonal
views of the superposition of the envelope model obtained by SASHA (30)
(shaded envelope) with the model based on two IL-22 high-resolution
structures (shaded lines) (24). (B) Three orthogonal views of the superposition
of the dummy residues model obtained by DAMMIN (30), as an average of
20 independent simulations (shaded spheres), with the model based on two
IL-22 high-resolution monomer structures (dark shaded ribbons) (24). (C)
Stereoview of the IL-22 dimer model (dark shaded ribbons) superimposed on
the IL-10 intertwined dimer (light shaded ribbons).
FIGURE 5 : SAXS ab initio envelope for IL-22 tetramer and proposed
high-resolution model based on IFN-g tetramer. (A) Three orthogonal views
of the superposition of the envelope model obtained by SASHA (30) and
shown as a shaded envelope with the model based on two IL-22 dimer
models (shaded lines) (24). (B) Three orthogonal views of the superposition
of the dummy residues model obtained by DAMMIN (30), as an average of
20 independent simulations (shaded spheres), with the model based on two
IL-22 high-resolution dimeric structures (dark and light ribbons) (24). (C)
Stereoview of the IL-22 tetramer model (solid ribbons) superimposed on the
IFN-g tetramer (shaded ribbons).
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DISCUSSION
In this work we report the ab initio, low-resolution models of
IL-22 alone and as a complex with its cognate receptor, IL-
22R1, generated from the synchrotron small angle x-ray
scattering data. IL-22 forms dimers or tetramers in solution,
depending on the protein concentration. The dimer is an
open V-shaped molecule and the tetramer adopts a partially
twisted X-shaped conformation. Our experimental x-ray
scattering data can be fitted very well with the V-shaped IL-
22 high-resolution model (Fig. 1 A). The distance distribu-
tion function based on V-shaped dimer is also consistent
with the experimentally derived one (Fig. 2 A). Moreover,
there is a very good agreement between the low-resolution
shapes of the IL-22 dimers and the proposed V-shaped
quaternary arrangement, which we found to be similar to the
IL-10 cytokine structure (Fig. 4 C). However, IL-10 dimer-
ization is mediated by the swapping of the helices C and D of
its a-helix bundle (22), whereas IL-22 dimerization interface
is mediated by residues on the surface of the protein. This is
surprising because surface residues are generally the first to
be mutated under evolutionary pressure, since such substi-
tutions usually do not interfere with the protein fold and
overall three-dimensional structure. It is important to stress
that the asymmetric dimer arrangement observed in IL-22
crystal structure (24) is not consistent with our solution
SAXS data. Based on our low-resolution model we propose
an explanation for the V-shaped dimeric association of IL-22
in solution as follows.
The IL-22 rigid body model obtained with MASHA (30)
is a V-shaped molecule in which the loop DE composes the
interface of dimerization (Fig. 7 A, left panel). At this inter-
face, protein-protein association might be mediated by three
types of interactions:
1. Central hydrophobic interactions via Ile-134.
2. Electrostatic binding interaction of His-133 and nega-
tively charged Glu-135 side chains.
3. A hydrogen-bond type interaction which might be medi-
ated by Thr-131 and Asp-137 (Fig. 7 A, right panel).
Given the twofold symmetry of the dimer, both loops are
in juxtaposition, allowing for their mutual interactions.
Crystal structures of IL-22 expressed in E. coli and S2
insect cells were obtained, respectively, at pH values close to
7 and 6. At such pH values, the His-133 side chain is
charged, which might weaken IL-22 dimers, possibly lead-
ing to their dissociation, and formation of alternative asym-
metric dimeric forms observed in crystals. In line with this
hypothesis, alignment of helix D, loop DE, and helix E
amino acids of IL-22 from human, monkey, dog, and cow,
shows conservation for the potential residues involved in
dimerization contacts in these species (Fig. 7 B). To examine
this hypothesis, mutagenesis studies of key interface residues
are currently under way.
There is well-documented evidence of a number of pro-
teins whose multimeric arrangements are different in crystals
and in solution, similarly to the differences between solution
and crystallographic IL-22 structures. Indeed, x-ray diffrac-
tion data provide a wealth of high-resolution information
about proteins secondary and tertiary structures, but are not
necessarily effective for their quaternary structural analysis.
These molecular arrangements are susceptible to appearance
of spurious multimeric forms which can be observed in a
crystal as a result of high precipitant, protein concentrations,
and nonphysiological pHs used under crystallization condi-
tions. For example, ferredoxin reductases were also crystal-
lized as dimers (39,40), but are known to act as monomers in
solution (41). Conversely, both yeast hexokinase and bovine
b-lactoglobulin, which are capable of forming dimers in
FIGURE 6 SAXS ab initio envelope for IL-22/IL-22R1 dimer and
proposed high-resolution model based on IL-10/IL-10R1. (A) Three
orthogonal views of the superposition of the envelope model obtained by
SASHA (30) displayed as a shaded envelope, with IL-22/IL-22R1 high-
resolution complex (shaded lines). (B) Three orthogonal views of the super-
position of the dummy residues model obtained by DAMMIN (30), as an
average of 20 independent simulations (shaded spheres), with IL-22/IL22R1
high-resolution complex (cartoons). (C) Stereoview of the IL-10/IL-10R1
structure (PDB ID: 1J7V) (cartoons). (D) Putative IL-22/IL-22R1/IL-22R2
molecular interfaces. The amino-acid residues implicated in interactions
with IL-22R2 receptor (50) are shown in solid spheres and are confined in
the vicinity of the IL-22/IL-22R1 molecular interface.
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solution (42–44), were observed as monomers in a crystal
(45–48). These evidences, together with IL-22 structural
differences between its solution and crystal organizations,
indicate that the protein structure observed in solution should
be more closely related to the functional form in vivo.
Therefore, the fact that the IL-22 monomers arrange
themselves in solution as dimers, which closely resembles
intertwined IL-10s, might have functional implications.
Indeed, comparison of the IL-22 solution model with IL-
10/IL-10R1 high-affinity receptor complex (11) demon-
strates that the IL-22 dimer adopts position and orientation
which could be functionally productive for IL-22R1 receptor
recognition. Such IL-22/IL-22R1 complex would create
molecular interfaces similar to those of IL-10/IL-10R1
complex (11,17–19,49,50), which could be recognized by
the extracellular cytokine-binding domain of IL-10R2. This
molecule is a common receptor chain shared by both cyto-
kines (IL-22 and IL-10), and this further strengthens our
hypothesis of the putative physiological relevance of the
observed IL-22 dimer.
To obtain compelling evidence to support our hypothesis
of the physiological importance of the IL-22 dimers, we
determined the solution low-resolution structure of the com-
plex IL-22/IL-22R1. The model given in Fig. 6, A and B,
shows dimeric IL-22 bound to two IL-22R1 receptor chains.
The V-angle observed for soluble IL-22 dimers becomes
more open when the cytokines bind to IL-22R1s, due to the
interactions between N-terminal regions of IL-22R1s and as
a result of the weaker IL-22 dimer interface mediated by the
flexible loop DE. However, the identity in stoichiometry and
similarity of the quaternary structures between IL-22/IL-
22R1 and IL-10/IL-10R1 complexes are evident, further
supporting a notion of the physiological relevance of the
IL-22 dimers.
Low-resolution structure of IL-22/IL22-R1 complex helps
to shed light on a molecular assembly of IL-22 with its
soluble receptor, IL-22BP. IL-22BP, and IL-22R1 have
;34% of amino-acid sequence identity. Moreover, IL-22BP
also competes with IL-22R1 for IL-22, which is indicative
of least partial overlap in their IL-22 binding sites (3). The
collective evidence points toward putative structural simi-
larities in IL-22/IL-22BP and IL-22/IL-22R1 quaternary
organizations, and allows one to argue that IL-22/IL-22BP
architecture should be grossly similar to that of IL-22/IL-22R1
(Fig. 6 A). Furthermore, the present IL-22/IL-22R1 model
permits us to speculate about IL-22/IL-22R1/IL-22R2 ternary
complex assembly. It is known that IL-22R2 recognizes
specific peptides in helices A and D of IL-22 (50). Mapping of
the correspondent residues on our low-resolution model of
IL-22/IL-22R1 binary complex reveals that in agreement with
previous studies (19,50) these peptides are at, or close to, the
interface between IL-22 and IL-22R1 (Fig. 6 D). Hence, it is
probable that the surface areas of IL-22R1 in the vicinity of
the binary complex interface might also participate in IL-22R2
recognition and the ternary complex formation. This model is
consistent with the sequential mechanism of IL-22 ternary
complex formation (17–19). However, much more thorough
studies are required to elucidate structural details of the binary
(IL-22/IL-22BP) and ternary (IL-22/IL-22R1/IL-22R2) com-
plex assemblies.
The twisted X-shaped conformation of IL-22 tetramer is
another novel finding from our study. The low-resolution
scattering showed that its quaternary structure is composed
of two V-shaped IL-22 dimers (Fig. 5, A and B). We found
FIGURE 7 Putative IL-22 dimerization interface.
(A) Top view of IL-22 dimer (left panel). Interaction
between two DE loops (solid box on the left panel)
are shown in detail in the right panel. (B) Alignment
of IL-22 amino-acid sequences of helix D, loop DE,
and helix E of human (Genbank entry AJ277247),
monkey (XP_001117159), dog (XP_538274), and
cow (XP_584453) homologs. The conserved poten-
tial residues involved in DE loop interaction are
indicated (asterisks inside the box).
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that this arrangement is similar to that of crystallographic
single-chain monovalent human interferon-g, described pre-
viously (10) (Fig. 5 C). The ScIFN-g was made by dupli-
cation of IFN-g sequence and linking the C-terminal end of
one copy to the N-terminus of the second one. Such hybrid
molecule folds similarly to the IFN-g intimate intertwined
dimer (with the difference that both IFN-g polypeptide se-
quences belong now to the same polypeptide chain), but
recognizes only one IFN-gR1 high-affinity receptor chain
though the intermolecular interactions mostly involving
helices A, B, and the loop connecting them (residues 1–34)
(10). The second binding site of such chimera becomes ob-
structed most probably by restraints imposed by the linker
peptide on the conformation of helices A, B, and the con-
necting loop. A similarity between the molecular shapes of the
IL-22 tetramer and the ScIFN-g is indeed striking (Fig. 5 C).
Comparison of the IL-22 tetramers (Fig. 5) with the IL-22/
IL-22R1 molecular complexes (Fig. 6) shows that the inter-
actions of IL-22s with IL-22R1s lead to the major rearrange-
ments in the relative conformation of the IL-22 monomers
within a dimer and in significant increase in the V-angle of the
IL-22 dimer observed in the absence of the cognate receptor.
Furthermore, the molecular interfaces of two dimers forming
a tetramer and of the IL-22/IL-22R1 complex partially
overlap. Therefore, molecular interactions of IL-22 with the
cognate receptormust lead to the dissociation of the tetrameric
form of IL-22. A similar self-association of proteins into
higher multimeric forms has been described previously. For
example, a retinoid X receptor forms tetramers, which dis-
sociate into functionally active dimers upon interaction with
ligands and/or DNA response elements (51,52). Retinoid X
receptor tetramers are considered to function as a reservoir
of inactive protein which becomes readily available in an
active, dimeric, form on request from the physiological
stimuli (53). Recently another member of the nuclear receptor
family, thyroid hormone nuclear receptor, was also found to
form tetramers, which dissociate into dimers on hormone or
cognate DNA signal (54,55). Thus, it is tempting to speculate
that IL-22 tetramers might in fact represent a nonactive form
of the cytokine which is formed at high protein concentrations
and dissociate into the active, lower multimeric forms upon
interaction with the cognate cellular receptors.
IL-22 functional form was predicted to be a monomer, a
result which was later experimentally supported by surface
plasmon resonance experiments (18,19). The fact that IL-22
is capable of monomer formation prompted speculations that
IL-22 recruits one IL-22R1 and one IL-10R2 to form a
functional IL-22/receptor complex, unlike IL-10, which
binds two IL-10R1s and two IL-10R2s to a functional
intertwined dimer (18). It is important to mention that surface
plasmon resonance experiments have been conducted with
IL-22 protein that was immobilized at a concentration of 5
mg/ml in 10 mM sodium acetate buffer pH 5.0 (18). Under
this pH, His-133 is uncharged—a condition which, accord-
ing to our model for dimer interaction, prevents IL-22
dimerization. We conducted a number of biochemical and
biophysical experiments at pH 8 and propose SAXS models
which show that IL-22 forms dimers and tetramers in
solution. The V-shaped dimer and the partially twisted
X-shaped molecular arrangements were also observed bio-
chemically. The molecular weights of such species were in-
dependently obtained by DLS, glutaraldehyde cross-linking,
and native PAGE (Fig. 3), supporting the SAXS models, and
indicating that dimer and tetramer species are in thermody-
namic equilibrium. Our data are also coherent with the
previous biochemical reports, based on cross-linking studies,
showing that IL-22 forms oligomers with its receptors in
hamster cells (13). We also determined the solution structure
of the IL-22/IL-22R1 complex, which reveals the IL-22 di-
mer being recognized by two IL-22R1 high-affinity receptor
chains. This molecular assembly lends support to a hypoth-
esis that the IL-22 dimeric state has a physiological relevance
and that this quaternary arrangement could be physiologi-
cally significant at high cytokine concentrations and under
cellular settings in which an amplified molecular response is
required. The differences in the observed IL-22 multimeric
forms with the previous plasmon resonance studies presum-
ably stem from the lower concentrations of the cytokine ac-
cessible under such experiments, which are likely to represent
conditions of IL-22 interactions with the cognate receptors
under very low cytokine concentrations.
Furthermore, our results propose a model which unifies
interleukin/receptor stoichiometry models. It was shown
previously that IL-22 (and related cytokines IL-19 and IL-
20) form 1:1:1 stoichiometric complexes with correspondent
receptor chains, whereas IL-10 (as well as IFN-g) intimate
intertwined dimers are recognized by their cognate mem-
brane receptors in 1:2:2 stoichiometry (1–3,10,11,13,14,
17–19). V-shaped dimers of IL-22 offer a possibility to bind
IL-22R1 and IL-10R2 receptors in 1:2:2 stoichiometry,
while preserving a 1:1:1 molar ratio for the IL-22 monomer.
The concentration of IL-22 was already determined for
physiological and pathological conditions. In patients with
psoriasis, a chronic inflammatory skin disease, the IL-22
serum concentration is ;80-fold higher than the concentra-
tion observed for healthy donors (56). This elevated IL-22
plasma level correlates with the disease severity. In partic-
ular, patients with severe psoriasis have blood IL-22 con-
centrations of ;76 pg/ml (56). Such low concentrations
of the protein are beyond the sensitivity of our experimental
techniques. At these concentrations, when IL-22 acts as an
endocrine factor, IL-22 would be expected to be monomeric.
However, local concentration of this cytokine in inflamma-
tory focus may be increased in several orders of magnitude
when compared to serum concentrations driving the ther-
modynamic equilibrium to form dimeric and/or tetrameric
species. Given the practical limitation in the determination of
protein concentration in situ, we speculate that the oligo-
meric species demonstrated in this work can be present in
inflammatory focus, e.g., dermatoses, where protein IL-22
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concentration is increased. In line with our proposal, we
observed, in native gel electrophoresis, IL-22 dimers at
concentrations as low as 1 mg/ml (data not shown). The local
cytokine concentration close to the cell surface and the
dimer-dimer affinities could be significantly higher for the
functional cytokine dimers bound to the extracellular
domains of class-2 cytokine receptors. It was shown, for
example, that the binding affinities of the molecules in the
two-dimensional diffusion case are significantly (orders-
of-magnitude) higher than that observed in solution (57).
Therefore, affinities of multimers association are expected to
be substantially enhanced when cytokines are bound to the
receptors anchored in the membrane, similarly to what is
observed in the follicle-stimulating hormone-receptor inter-
actions (58). We expect, therefore, that IL-22 might be pres-
ent in multimeric forms in diseases, particularly in peripheral
tissues, generated in the chronic psoriatic plaques.
Furthermore, physiological effect of cytokine/receptors
recognition seems to be cumulative. ScIFN-g, for example,
which contains only one productive cognate receptor binding
site, retains only 1% of the physiological activity of the wild-
type IFN-g (10). We hypothesize that the ability of IL-22 to
form dimers bound simultaneously to two IL-22R1 and two
IL-10R2 receptor chains (1:2:2 stoichiometry) could be used
by the cell to amplify molecular signals conducted by this
cytokine.
All these data collectively suggest that the concentration-
dependent dimerization of monomeric cytokines might be a
common theme in their molecular recognition by respective
cellular receptors, and that dimeric quaternary structures of
these cytokines, along with the monomeric forms, are likely
to be of functional importance.
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